<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39442133</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>25</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2965-2774</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Critical care science</Title><ISOAbbreviation>Crit Care Sci</ISOAbbreviation></Journal><ArticleTitle>Comparison of the effectiveness of awake-prone positioning and high-flow nasal oxygen in patients with COVID-19-related acute respiratory failure between different waves.</ArticleTitle><Pagination><StartPage>e20240065en</StartPage><MedlinePgn>e20240065en</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e20240065en</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.62675/2965-2774.20240065-en</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2965-27742024000100320</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To compare the effectiveness of the awake-prone position on relevant clinical outcomes in patients with COVID-19-related acute respiratory failure requiring high-flow nasal oxygen between different waves in Argentina.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This multicenter, prospective cohort study included adult patients with COVID-19-related acute respiratory failure requiring high-flow nasal oxygen. The main exposure position was the awake-prone position (≥ 6 hours/day) compared to the non-prone position. The primary outcome was endotracheal intubation, and the secondary outcome was in-hospital mortality. The inverse probability weighting-propensity score was used to adjust the conditional probability of treatment assignment. We then adjusted for contextual variables that varied over time and compared the effectiveness between the first and second waves.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 728 patients were included: 360 during the first wave and 368 during the second wave, of whom 195 (54%) and 227 (62%) remained awake-prone for a median (p25 - 75) of 12 (10 - 16) and 14 (8 - 17) hours/day, respectively (Awake-Prone Position Group). The ORs (95%CIs) for endotracheal intubation in the Awake-Prone Position Group were 0.25 (0.13 - 0.46) and 0.19 (0.09 - 0.31) for the first and second waves, respectively (p = 0.41 for comparison between waves). The ORs for in-hospital mortality in the awake-prone position were 0.35 (0.17 - 0.65) and 0.22 (0.12 - 0.43), respectively (p = 0.44 for comparison between waves).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The awake-prone position was associated with a reduction in the risk of endotracheal intubation and in-hospital mortality. These effects were independent of the context in which the intervention was applied, and no differences were observed between the different waves.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Esperatti</LastName><ForeName>Mariano</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-3098-9393</Identifier><AffiliationInfo><Affiliation>Intensive Care Department, Hospital Privado de Comunidad, Escuela Superior de Medicina, Universidad Nacional de Mar del Plata - Mar del Plata, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olmos</LastName><ForeName>Matías</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-8467-0815</Identifier><AffiliationInfo><Affiliation>Intensive Care Department, Hospital Privado de Comunidad, Escuela Superior de Medicina, Universidad Nacional de Mar del Plata - Mar del Plata, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Busico</LastName><ForeName>Marina</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8377-6477</Identifier><AffiliationInfo><Affiliation>Intensive Care Unit, Clínica Olivos, Swiss Medical Group - Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gallardo</LastName><ForeName>Adrian</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-9729-4839</Identifier><AffiliationInfo><Affiliation>Intensive Care Unit, Sanatorio Clínica Modelo de Morón - Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vitali</LastName><ForeName>Alejandra</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-0199-816X</Identifier><AffiliationInfo><Affiliation>Intensive Care Unit, Sanatorio de la Trinidad Palermo - Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quintana</LastName><ForeName>Jorgelina</ForeName><Initials>J</Initials><Identifier Source="ORCID">0009-0002-3846-5279</Identifier><AffiliationInfo><Affiliation>Intensive Care Unit, Clínica Olivos, Swiss Medical Group - Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kakisu</LastName><ForeName>Hiromi</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-5321-5011</Identifier><AffiliationInfo><Affiliation>Intensive Care Department, Hospital Privado de Comunidad, Escuela Superior de Medicina, Universidad Nacional de Mar del Plata - Mar del Plata, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferreyro</LastName><ForeName>Bruno Leonel</ForeName><Initials>BL</Initials><Identifier Source="ORCID">0000-0001-7485-3741</Identifier><AffiliationInfo><Affiliation>Interdepartmental Division of Critical Care Medicine, University of Toronto - Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fuentes</LastName><ForeName>Nora Angélica</ForeName><Initials>NA</Initials><Identifier Source="ORCID">0000-0002-4893-3374</Identifier><AffiliationInfo><Affiliation>Intensive Care Department, Hospital Privado de Comunidad, Escuela Superior de Medicina, Universidad Nacional de Mar del Plata - Mar del Plata, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Argentine Collaborative Group on High Flow and Prone Positioning</CollectiveName></Author><Author ValidYN="Y"><LastName>Osatnik</LastName><ForeName>Javier</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, Hospital Alemão - Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saavedra</LastName><ForeName>Santiago Nicolas</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, Hospital Alemão - Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matarrese</LastName><ForeName>Agustin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, Hospital Alemão - Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Niquin</LastName><ForeName>Greta Dennise Rebaza</ForeName><Initials>GDR</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, Hospital Alemão - Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wasinger</LastName><ForeName>Elizabeth Gisele</ForeName><Initials>EG</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, Hospital Universitario Austral - Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mast</LastName><ForeName>Giuliana</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, Hospital Universitario Austral - Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andrada</LastName><ForeName>Facundo Juan</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, Hospital Universitario Austral - Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lagazio</LastName><ForeName>Ana Inés</ForeName><Initials>AI</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, Clínica Olivos - Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romano</LastName><ForeName>Nahuel Esteban</ForeName><Initials>NE</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, Clínica Olivos - Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laiz</LastName><ForeName>Marisol Mariela</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, Clínica Olivos - Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Urrutia</LastName><ForeName>Jose Garcia</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, Clínica Olivos - Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mogaadouro</LastName><ForeName>Mariela Adriana</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, Sanatorio de la Trinidad Palermo - Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seifert</LastName><ForeName>Micaela Ruiz</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, Sanatorio de la Trinidad Palermo - Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mastroberti</LastName><ForeName>Emilce</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, Sanatorio de la Trinidad Palermo - Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreno</LastName><ForeName>Claudia Navarro</ForeName><Initials>CN</Initials><AffiliationInfo><Affiliation>Intensive Care Department, Hospital Privado de Comunidad - Mar del Plata, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tirado</LastName><ForeName>Anabel Miranda</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Intensive Care Department, Hospital Privado de Comunidad - Mar del Plata, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viñas</LastName><ForeName>María Constanza</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Intensive Care Department, Hospital Privado de Comunidad - Mar del Plata, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pintos</LastName><ForeName>Juan Manuel</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Intensive Care Department, Hospital Privado de Comunidad - Mar del Plata, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzalez</LastName><ForeName>Maria Eugenia</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Intensive Care Department, Hospital Privado de Comunidad - Mar del Plata, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mateos</LastName><ForeName>Maite</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Intensive Care Department, Hospital Privado de Comunidad - Mar del Plata, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barbaresi</LastName><ForeName>Verónica</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Intensive Care Department, Hospital Privado de Comunidad - Mar del Plata, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grimbeek</LastName><ForeName>Ana Elizabeth</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Intensive Care Department, Hospital Privado de Comunidad - Mar del Plata, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stein</LastName><ForeName>Leonel</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Intensive Care Department, Hospital Privado de Comunidad - Mar del Plata, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Latronico</LastName><ForeName>Ariel Juan</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Intensive Care Department, Hospital Privado de Comunidad - Mar del Plata, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Menéndez</LastName><ForeName>Silvia Laura</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Intensive Care Department, Hospital Privado de Comunidad - Mar del Plata, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Basualdo</LastName><ForeName>Alejandra Dominga</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Intensive Care Department, Hospital Privado de Comunidad - Mar del Plata, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castrillo</LastName><ForeName>Romina</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Intensive Care Department, Hospital Privado de Comunidad - Mar del Plata, Argentina.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><Language>por</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Crit Care Sci</MedlineTA><NlmUniqueID>9918627781706676</NlmUniqueID><ISSNLinking>2965-2774</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016684" MajorTopicYN="N">Prone Position</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010102" MajorTopicYN="Y">Oxygen Inhalation Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001118" MajorTopicYN="N" Type="Geographic">Argentina</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007442" MajorTopicYN="Y">Intubation, Intratracheal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056888" MajorTopicYN="N">Patient Positioning</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014851" MajorTopicYN="N">Wakefulness</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012131" MajorTopicYN="N">Respiratory Insufficiency</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="por"><AbstractText Label="OBJETIVO:">Comparar a eficácia da posição prona consciente nos desfechos clínicos relevantes em pacientes com insuficiência respiratória aguda relacionada à COVID-19 que necessitaram de oxigênio nasal de alto fluxo em diferentes ondas da doença na Argentina.</AbstractText><AbstractText Label="MÉTODOS:">Trata-se de estudo de coorte prospectivo e multicêntrico, que incluiu pacientes adultos com insuficiência respiratória aguda relacionada à COVID-19 que necessitaram de oxigênio nasal de alto fluxo. A principal posição de exposição foi a prona consciente (≥ 6 horas/dia) em comparação com a prona não consciente. O desfecho primário foi a intubação endotraqueal, e o secundário foi a mortalidade hospitalar. Utilizou-se o escore de propensão de ponderação pela probabilidade inversa para ajustar a probabilidade condicional de atribuição de tratamento. Em seguida, ajustamos as variáveis contextuais, que variaram ao longo do tempo e comparamos a eficácia entre a primeira e a segunda onda.</AbstractText><AbstractText Label="RESULTADOS:">Ao todo, 728 pacientes foram incluídos: 360 durante a primeira onda e 368 durante a segunda onda, dos quais 195 (54%) e 227 (62%) permaneceram em prona consciente numa mediana (intervalo interquatil 25 - 75%) de 12 (10 - 16) e 14 (8 - 17) horas/dia, respectivamente (Grupo Prona Consciente). As razões de chance (intervalo de confiança de 95%) de intubação endotraqueal no grupo prona em vigília foram de 0,25 (0,13 - 0,46) e 0,19 (0,09 - 0,31) na primeira e segunda ondas, respectivamente (p = 0,41 comparativamente entre as ondas). As razões de chance de mortalidade intra-hospitalar na posição prona consciente foram de 0,35 (0,17 - 0,65) e 0,22 (0,12 - 0,43), respectivamente (p = 0,44 comparativamente entre as ondas).</AbstractText><AbstractText Label="CONCLUSÃO:">A posição prona consciente foi associada à redução no risco de intubação endotraqueal e mortalidade hospitalar. Esses efeitos foram independentes do contexto em que a intervenção foi aplicada e não foram observadas diferenças entre as diferentes ondas.</AbstractText></OtherAbstract><CoiStatement><b>Conflicts of interest:</b> Marina Busico received lecture fees from Tecme S.A. and MEDIX Medical Devices S.R.L., Argentina. Marina Busico, Adrian Gallardo, Alejandra Vitali and Hiromi Kakisu reports financial support provided by Salud Investiga Grant, Ministry of Health of the Nation, Argentina. The rest of the authors declare to have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>24</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>22</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>16</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39442133</ArticleId><ArticleId IdType="pmc">PMC11484112</ArticleId><ArticleId IdType="doi">10.62675/2965-2774.20240065-en</ArticleId><ArticleId IdType="pii">S2965-27742024000100320</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239–1242.</Citation><ArticleIdList><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes LF, Murthy S, Garcia-Gallo E, Merson L, Ibáñez-Prada ED, Rello J, Fuentes YV, Martin-Loeches I, Bozza F, Duque S, Taccone FS, Fowler RA, Kartsonaki C, Gonçalves BP, Citarella BW, Aryal D, Burhan E, Cummings MJ, Delmas C, Diaz R, Figueiredo-Mello C, Hashmi M, Panda PK, Jiménez MP, Rincon DFB, Thomson D, Nichol A, Marshall JC, Olliaro PL, ISARIC Characterization Group Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study. Crit Care. 2022;26(1):276–276.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9469080</ArticleId><ArticleId IdType="pubmed">36100904</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehrmann S, Li J, Ibarra-Estrada M, Perez Y, Pavlov I, McNicholas B, Roca O, Mirza S, Vines D, Garcia-Salcido R, Aguirre-Avalos G, Trump MW, Nay MA, Dellamonica J, Nseir S, Mogri I, Cosgrave D, Jayaraman D, Masclans JR, Laffey JG, Tavernier E, Awake Prone Positioning Meta-Trial Group Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial. Lancet Respir Med. 2021;9(12):1387–1395.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8378833</ArticleId><ArticleId IdType="pubmed">34425070</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Luo J, Pavlov I, Perez Y, Tan W, Roca O, Tavernier E, Kharat A, McNicholas B, Ibarra-Estrada M, Vines DL, Bosch NA, Rampon G, Simpson SQ, Walkey AJ, Fralick M, Verma A, Razak F, Harris T, Laffey JG, Guerin C, Ehrmann S, Awake Prone Positioning Meta-Analysis Group Awake prone positioning for non-intubated patients with COVID-19-related acute hypoxaemic respiratory failure: a systematic review and meta-analysis. Lancet Respir Med. 2022;10(6):573–583.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8926412</ArticleId><ArticleId IdType="pubmed">35305308</ArticleId></ArticleIdList></Reference><Reference><Citation>Greco M, De Corte T, Ercole A, Antonelli M, Azoulay E, Citerio G, Morris AC, De Pascale G, Duska F, Elbers P, Einav S, Forni L, Galarza L, Girbes ARJ, Grasselli G, Gusarov V, Jubb A, Kesecioglu J, Lavinio A, Delgado MCM, Mellinghoff J, Myatra SN, Ostermann M, Pellegrini M, Povoa P, Schaller SJ, Teboul JL, Wong A, De Waele JJ, Cecconi M, ESICM UNITE-COVID investigators Clinical and organizational factors associated with mortality during the peak of first COVID-19 wave: the global UNITE-COVID study. Intensive Care Med. 2022;48(6):690–705.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9123859</ArticleId><ArticleId IdType="pubmed">35596752</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurtz P, Bastos LS, Dantas LF, Zampieri FG, Soares M, Hamacher S, et al. Evolving changes in mortality of 13,301 critically ill adult patients with COVID-19 over 8 months. Intensive Care Med. 2021;47(5):538–548.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8044656</ArticleId><ArticleId IdType="pubmed">33852032</ArticleId></ArticleIdList></Reference><Reference><Citation>Rearte A, Castelli JM, Rearte R, Fuentes N, Pennini V, Pesce M, et al. Effectiveness of rAd26-rAd5, ChAdOx1 nCoV-19, and BBIBP-CorV vaccines for risk of infection with SARS-CoV-2 and death due to COVID-19 in people older than 60 years in Argentina: a test-negative, case-control, and retrospective longitudinal study. Lancet. 2022;399(10331):1254–1264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8923678</ArticleId><ArticleId IdType="pubmed">35303473</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson OJ, Barnsley G, Toor J, Hogan AB, Winskill P, Ghani AC. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. Lancet Infect Dis. 2022;22(9):1293–1302.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9225255</ArticleId><ArticleId IdType="pubmed">35753318</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauring AS, Hodcroft EB. Genetic variants of SARS-CoV-2—What do they mean? JAMA. 2021;325(6):529–531.</Citation><ArticleIdList><ArticleId IdType="pubmed">33404586</ArticleId></ArticleIdList></Reference><Reference><Citation>Chadha J, Khullar L, Mittal N. Facing the wrath of enigmatic mutations: a review on the emergence of severe acute respiratory syndrome coronavirus 2 variants amid coronavirus disease-19 pandemic. Environ Microbiol. 2022;24(6):2615–2629.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8441773</ArticleId><ArticleId IdType="pubmed">34320263</ArticleId></ArticleIdList></Reference><Reference><Citation>Boehm E, Kronig I, Neher RA, Eckerle I, Vetter P, Kaiser L, Geneva Centre for Emerging Viral Diseases Novel SARS-CoV-2 variants: the pandemics within the pandemic. Clin Microbiol Infect. 2021;27(8):1109–1117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8127517</ArticleId><ArticleId IdType="pubmed">34015535</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger M, STROBE Initiative Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Int J Surg. 2014;12(12):1500–1524.</Citation><ArticleIdList><ArticleId IdType="pubmed">25046751</ArticleId></ArticleIdList></Reference><Reference><Citation>Esperatti M, Busico M, Fuentes NA, Gallardo A, Osatnik J, Vitali A, Wasinger EG, Olmos M, Quintana J, Saavedra SN, Lagazio AI, Andrada FJ, Kakisu H, Romano NE, Matarrese A, Mogadouro MA, Mast G, Moreno CN, Niquin GD, Barbaresi V, Bruhn Cruz A, Ferreyro BL, Torres A, Argentine Collaborative Group on High Flow and Prone Positioning Impact of exposure time in awake prone positioning on clinical outcomes of patients with COVID-19-related acute respiratory failure treated with high-flow nasal oxygen: a multicenter cohort study. Crit Care. 2022;26(1):16–16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8740872</ArticleId><ArticleId IdType="pubmed">34996496</ArticleId></ArticleIdList></Reference><Reference><Citation>Irassar JI, Bartel E, Obando D, Varela T. Comparación epidemiológica de las olas por COVID-19 en la provincia de Buenos Aires, Argentina, 2020-2021. Rev Argent Salud Pública. 2022;14(Supl COVID-19):e-49</Citation></Reference><Reference><Citation>Frat J-P, Thille AW, Mercat A, Girault C, Ragot S, Perbet S, Prat G, Boulain T, Morawiec E, Cottereau A, Devaquet J, Nseir S, Razazi K, Mira JP, Argaud L, Chakarian JC, Ricard JD, Wittebole X, Chevalier S, Herbland A, Fartoukh M, Constantin JM, Tonnelier JM, Pierrot M, Mathonnet A, Béduneau G, Delétage-Métreau C, Richard JC, Brochard L, Robert R, FLORALI Study Group REVA Network. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med. 2015;372(15):2185–2196.</Citation><ArticleIdList><ArticleId IdType="pubmed">25981908</ArticleId></ArticleIdList></Reference><Reference><Citation>Roca O, Caralt B, Messika J, Samper M, Sztrymf B, Hernández G, et al. An index combining respiratory rate and oxygenation to predict outcome of nasal high-flow therapy. Am J Respir Crit Care Med. 2019;199(11):1368–1376.</Citation><ArticleIdList><ArticleId IdType="pubmed">30576221</ArticleId></ArticleIdList></Reference><Reference><Citation>Francone M, Iafrate F, Masci GM, Coco S, Cilia F, Manganaro L, et al. Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis. Eur Radiol. 2020;30(12):6808–6817.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7334627</ArticleId><ArticleId IdType="pubmed">32623505</ArticleId></ArticleIdList></Reference><Reference><Citation>Xian Y, O’Brien EC, Fonarow GC, Olson DM, Schwamm LH, Hannah D, et al. Patient-centered research into outcomes stroke patients prefer and effectiveness research: implementing the patient-driven research paradigm to aid decision making in stroke care. Am Heart J. 2015;170(1):36–45. 45.e1-11.</Citation><ArticleIdList><ArticleId IdType="pubmed">26093862</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC, Stuart EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med. 2015;34(28):3661–3679.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4626409</ArticleId><ArticleId IdType="pubmed">26238958</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70(1):41–55.</Citation></Reference><Reference><Citation>Etminan M, Collins GS, Mansournia MA. Using causal diagrams to improve the design and interpretation of medical research. Chest. 2020;158(1S):S21–S28.</Citation><ArticleIdList><ArticleId IdType="pubmed">32658648</ArticleId></ArticleIdList></Reference><Reference><Citation>Textor J, van der Zander B, Gilthorpe MS, Liśkiewicz M, Ellison GTH. Robust causal inference using directed acyclic graphs: the R package "dagitty.". Int J Epidemiol. 2016;45(6):1887–1894.</Citation><ArticleIdList><ArticleId IdType="pubmed">28089956</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46(3):399–424.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3144483</ArticleId><ArticleId IdType="pubmed">21818162</ArticleId></ArticleIdList></Reference><Reference><Citation>Deeks JJ, Higgins JP, Altman DG, editors; Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane Handbook for Systematic Reviews of Interventions. version 6.3 (updated February 2022) Cochrane: 2022. Chapter 10: Analysing data and undertaking meta-analyses. Available from  www.training.cochrane.org/handbook
.</Citation></Reference><Reference><Citation>VanderWeele TJ, Ding P. Sensitivity analysis in observational research: introducing the e-value. Ann Intern Med. 2017;167(4):268–274.</Citation><ArticleIdList><ArticleId IdType="pubmed">28693043</ArticleId></ArticleIdList></Reference><Reference><Citation>Wendel-Garcia PD, Moser A, Jeitziner MM, Aguirre-Bermeo H, Arias-Sanchez P, Apolo J, Roche-Campo F, Franch-Llasat D, Kleger GR, Schrag C, Pietsch U, Filipovic M, David S, Stahl K, Bouaoud S, Ouyahia A, Fodor P, Locher P, Siegemund M, Zellweger N, Cereghetti S, Schott P, Gangitano G, Wu MA, Alfaro-Farias M, Vizmanos-Lamotte G, Ksouri H, Gehring N, Rezoagli E, Turrini F, Lozano-Gómez H, Carsetti A, Rodríguez-García R, Yuen B, Weber AB, Castro P, Escos-Orta JO, Dullenkopf A, Martín-Delgado MC, Aslanidis T, Perez MH, Hillgaertner F, Ceruti S, Franchitti Laurent M, Marrel J, Colombo R, Laube M, Fogagnolo A, Studhalter M, Wengenmayer T, Gamberini E, Buerkle C, Buehler PK, Keiser S, Elhadi M, Montomoli J, Guerci P, Fumeaux T, Schuepbach RA, Jakob SM, Que YA, Hilty MP, RISC-19-ICU Investigators Dynamics of disease characteristics and clinical management of critically ill COVID-19 patients over the time course of the pandemic: an analysis of the prospective, international, multicentre RISC-19-ICU registry. Crit Care. 2022;26(1):199–199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9254551</ArticleId><ArticleId IdType="pubmed">35787726</ArticleId></ArticleIdList></Reference><Reference><Citation>Angriman F, Ferreyro BL, Burry L, Fan E, Ferguson ND, Husain S, et al. Interleukin-6 receptor blockade in patients with COVID-19: placing clinical trials into context. Lancet Respir Med. 2021;9(6):655–664.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8078877</ArticleId><ArticleId IdType="pubmed">33930329</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang H, Gu X, Tong Z. Effect of awake prone positioning in non-intubated COVID-19 patients with acute hypoxemic respiratory failure: a systematic review and meta-analysis. J Intensive Care Med. 2022;37(11):1493–1503.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9412157</ArticleId><ArticleId IdType="pubmed">36017576</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan W, Xu DY, Xu MJ, Wang ZF, Dai B, Li LL, et al. The efficacy and tolerance of prone positioning in non-intubation patients with acute hypoxemic respiratory failure and ARDS: a meta-analysis. Ther Adv Respir Dis. 2021;15:17534666211009407–17534666211009407.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8071979</ArticleId><ArticleId IdType="pubmed">33888007</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin DY, Gu Y, Xu Y, Wheeler B, Young H, Sunny SK, et al. Association of primary and booster vaccination and prior infection with SARS-CoV-2 infection and severe COVID-19 outcomes. JAMA. 2022;328(14):1415–1426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9513711</ArticleId><ArticleId IdType="pubmed">36155617</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendiola-Pastrana IR, López-Ortiz E, Río de la Loza-Zamora JG, González J, Gómez-García A, López-Ortiz G. SARS-CoV-2 variants and clinical outcomes: a systematic review. Life (Basel) 2022;12(2):170–170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8879159</ArticleId><ArticleId IdType="pubmed">35207458</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilcox ME, Rowan KM, Harrison DA, Doidge JC. Does unprecedented ICU capacity strain, as experienced during the COVID-19 pandemic, impact patient outcome? Crit Care Med. 2022;50(6):e548–e556.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9112508</ArticleId><ArticleId IdType="pubmed">35170537</ArticleId></ArticleIdList></Reference><Reference><Citation>República Argentina  Ministerio de Salud. COVID-19: Situación de nuevas variantes SARS-CoV-2 en Argentina. SE39/2021. Informe Técnico. Oct, 2021.  [access on July 20, 2023].  Available from:  https://www.argentina.gob.ar/sites/default/files/2021/10/vigilancia-genomica-se39_0.pdf
.</Citation></Reference><Reference><Citation>Halloran ME, Struchiner CJ, Longini IM., Jr Study designs for evaluating different efficacy and effectiveness aspects of vaccines. Am J Epidemiol. 1997;146(10):789–803.</Citation><ArticleIdList><ArticleId IdType="pubmed">9384199</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt M, Hajage D, Landoll M, Pequignot B, Langouet E, Amalric M, Mekontso-Dessap A, Chiscano-Camon L, Surman K, Finnerty D, Santa-Teresa P, Arcadipane A, Millán P, Roncon-Albuquerque R, Jr, Blandino-Ortiz A, Blanco-Schweizer P, Ricart P, Gimeno-Costa R, Albacete CL, Fortuna P, Schellongowski P, Dauwe D, Winiszewski H, Kimmoun A, Levy B, Hermans G, Grasselli G, Lebreton G, Guervilly C, Martucci G, Karagiannidis C, Riera J, Combes A, ECMO-SURGES Investigators Comparative outcomes of extracorporeal membrane oxygenation for COVID-19 delivered in experienced European centres during successive SARS-CoV-2 variant outbreaks (ECMO-SURGES): an international, multicentre, retrospective cohort study. Lancet Respir Med. 2023;11(2):163–175.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9889098</ArticleId><ArticleId IdType="pubmed">36640786</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibarra-Estrada M, Li J, Pavlov I, Perez Y, Roca O, Tavernier E, et al. Factors for success of awake prone positioning in patients with COVID-19-induced acute hypoxemic respiratory failure: analysis of a randomized controlled trial. Crit Care. 2022;26(1):84–84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8958810</ArticleId><ArticleId IdType="pubmed">35346319</ArticleId></ArticleIdList></Reference><Reference><Citation>Leisman DE. Ten pearls and pitfalls of propensity scores in critical care research: a guide for clinicians and researchers. Crit Care Med. 2019;47(2):176–185.</Citation><ArticleIdList><ArticleId IdType="pubmed">30543566</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>